✦ LIBER ✦

P.3.b.025 Plasma levels of risperidone in relation to dose, clinical improvement and side-effects in first-episode psychosis

✍ Scribed by Bustillo, M.; Alonso, M.; González-Pinto, A.; Segarra, R.; Zabala, A.; Román, S.; Ugarte, A.; García, J.; Santos, B.; Gutiérrez, M.

Book ID: 126902779
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 81 KB
Volume: 24
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(14)70809-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.c.054 Olanzapine, quetiapine, and ri

P.3.c.054 Olanzapine, quetiapine, and risperidone in the treatment of first-episode psychosis: effectiveness and factors influencing adherence to treatment

✍ J.P. McEvoy; D.O. Perkins; H. Gu; R.M. Hamer; J.A. Lieberman 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Usefulness of Plasma Haloperidol Levels

Usefulness of Plasma Haloperidol Levels for Monitoring Clinical Efficacy and Side Effects in Alzheimer Patients With Psychosis and Behavioral Dyscontrol

✍ Pelton, Gregory H.; Devanand, Devangere P.; Bell, Karen; Marder, Karen; Marston, 📂 Article 📅 2003 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 97 KB

P.3.c.024 Risperidone long-acting formul

P.3.c.024 Risperidone long-acting formulation in treatment-resistant schizophrenic patients: the predictive value of plasma levels in relation to clinical response and safety

✍ G. Cerveri; L.S. Volonteri; I. De Gasperi; B. Papini; P. Papa; M.C. Mauri; C. Me 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 95 KB